Innovation in Ireland →
Founding Director, Massachusetts Technology Transfer Center
Co-Founder and CEO, DNAnexus
Head of global research and development at Life Technologies
Medical College of Wisconsin director of research commercialization
Managing director, the Foundry Group
Executive Partner, Sofinnova Ventures
Founder, Gilt Groupe
Professor of Innovation at The University of Texas at Austin
September 30, 2015 ·
Acetylon is developing targeted HDAC inhibitor drugs.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.